<DOC>
	<DOC>NCT00820105</DOC>
	<brief_summary>Evaluation of ADX10059 to prevent migraine attacks</brief_summary>
	<brief_title>ADX10059 Migraine Prevention Study</brief_title>
	<detailed_description />
	<mesh_term>Migraine Disorders</mesh_term>
	<criteria>Male and female patients aged 18 to 65 years History of migraine Aged â‰¤ 50 years at onset of migraine history Cluster headache or chronic migraine headaches Currently uses, or within 3 months of Screening, has used: sodium valproate or topiramate and any other drugs used specifically for migraine prophylaxis, for example betablockers, calcium channel blockers, tricyclic antidepressants, selective serotonin reuptake inhibitors Unable to distinguish migraine headache from tension and other types of headache Current history of psychiatric disorder requiring regular medication Known history of alcohol abuse Known clinically significant allergy or known hypersensitivity to drugs History of a significant medical condition that may affect the safety of the patient or preclude adequate participation in the study Pregnant or breastfeeding</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>December 2009</verification_date>
	<keyword>Migraine</keyword>
	<keyword>Aura</keyword>
	<keyword>Migraine headache</keyword>
</DOC>